Global Biosimilar Contract Manufacturing Market By Product Type (Monoclonal Antibodies, Recombinant Proteins, Peptides, Granulocyte Colony-Stimulating Factor, Insulin, Epoetin, Interferon, Follitropin, Others) By Application, (Oncology, Autoimmune Diseases, Chronic Diseases, Infectious Diseases, Blood Disorders, Others) By Service Type (Process Development, Analytical Services, Fill and Finish, Regulatory Support, Commercial Manufacturing) By End User (Pharmaceutical Companies, Biotechnology Companies, Biosimilar Developers), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035
- Published date: April 2026
- Report ID: 185449
- Number of Pages: 238
- Format:
-
keyboard_arrow_up
-
-
- Lonza Group AG
- Samsung Biologics Co., Ltd.
- Boehringer Ingelheim BioXcellence
- FUJIFILM Diosynth Biotechnologies
- WuXi Biologics
- Celltrion Inc.
- Merck KGaA
- Thermo Fisher Scientific Inc.
- AGC Biologics
- Pfizer CentreOne
- AbbVie Contract Manufacturing
- Rentschler Biopharma SE
- Biocon Limited
- JRS Pharma
- ProBioGen AG
- Others
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible


